Your Solutions
BIOMEDTRACKER
Real-time Event Tracking & Drug Development Analysis
管線研發追蹤、獲批前景分析、商業資訊、調研報告
DATAMONITOR HEALTHCARE
Disease Competitive Analysis, 10-20 Years Market Forecast, KOL Insights
疾病競爭分析、10-20年市場預測、KOL專訪
Meet the team
Julie Guan (China)
Head of Strategic Accounts
Citeline
Youmin Zhu (China)
Client Success Manager
Citeline
Training & Help
We provide product training support via online sessions/pre-recorded materials, please click below to access relevant contents, or reach out to this email for any customized training request: [email protected]
我們提供各產品的使用培訓支持，請點擊下列查閲相關培訓資源，若有特定培訓需求或安排則可聯絡：[email protected]
For access or technical issues, please contact your dedicated support team via 'Meet the Team', or contact Client Service team via below email:
若有任何登錄問題，請切換至Meet the Team版面並聯絡對接服務團隊，或可聯絡全球/亞太客服團隊：
Global - [email protected] (English only)
APAC - [email protected] (via English/Chinese)
Require Research Support?
Ask-the-Analyst™
Ask-the-Analyst™
Your status as a loyalty partner includes unlimited access to our highly acclaimed Ask-the-Analyst™ service. With a 24-hour response time, Ask-the-Analyst offers you authoritative information to help you make faster, smarter business decisions.
作爲重點合作夥伴，貴司用戶均可無限量使用「Ask-the-Analyst™」分析師咨詢服務。分析師團隊將會在24小時内回復（工作日），并爲您提供信息收集或專業見解，最終助您做出更快、更明智的業務決策。
Our Ask-the-Analyst team of industry experts leverages the complete suite of pharma intelligence products and publicly available sources to bring you the answers you’re looking for, while your information and all questions received are strictly confidential.
由業界專家組成的Ask the Analyst團隊將結合内部數據與公開領域資源爲您提供相關信息支持，您的個人資訊與提問内容均會被嚴格保密。
Latest Pharma Monthly Newsletter
Edition: March 2026
EDITORIAL CONTENTS (incl. Podcasts, Webinars)
- Podcast: The State Of Facility Inspections With Two Former Senior US FDA Execs (Listen)
- Webinar: Pharma R&D Review Live 2026 (2pm GMT, April 21 | Register)
- Webinar: World Preview 2026 (2pm GMT, June 16 | Register)
DEALS & FINANCING (incl. M&As, Licensing, Financing)
- M&A: Lilly to Acquire Centessa for $6.3B Plus Earnouts
- M&A: Merck To Buy Terns Pharmaceuticals For $6.7B
- Licensing: Insilico Medicine Announces Global R&D Collaboration with Lilly totalling $2.75B ($115M upfront)
- Licensing: Chia Tai Enters into Global License Agreement with Sanofi for Rovadicitinib totalling $1.53B ($135M upfront)
- Financing: Medtronic’s Minimed Diabetes Unit Nets $537.6M in IPO
- Financing: Earendil Labs Secures $787M in Financing to Scale AI-Driven Biologics Discovery and Development
KEY R&D EVENTS (incl. Top-line Readouts, Analyst Commentary, Approval/CRL)
- Analysis: BioNTech | Gotistobart shows promise in squamous NSCLC at ELCC 2026, but safety concerns remain
- Analysis: Xenon Pharma | Azetukalner produces positive Phase III results in FOS; Xenon prepares for Q3 NDA submission
- Analysis: Apogee Therapeutics | Zumilokibart shows early promise as a differentiated, long acting IL 13 therapy in atopic dermatitis
- Analysis: Dizal Pharma | Zegfrovy emerges as a promising first-line option for EGFR exon 20 insertion NSCLC
- Analysis: NovaBridge Biosciences | NovaBridge sees path to accelerated approval for givastomig in gastric cancer after FDA meeting
- Analysis: uniQure | FDA reaffirms stance on AMT-130 in Huntington's disease, stating that a sham surgery-controlled study will be required for approval
- Analysis: Diamyd Medical | Disappointment as retogatein shows no C-peptide response in type 1 diabetics in Phase III DIAGNODE-3 study
RESEARCH REPORTS (incl. Forecast, Thought Leadership, KOL Interview)
- Report: Pharma R&D Annual Review 2026 Whitepaper
- Report: Orphan Drugs Outlook 2032: Sales, Pipeline & Policy for Rare Diseases
- Report: AI in Pharma 2026: From Insight to Execution in Clinical Trials
- Report: Article Spotlight: Focus on China
- Report: Bio Asia 2026 Conference Dispatch
- Report: Disease Analysis - Hidradenitis Suppurativa | Idiopathic Pulmonary Fibrosis (IPF)
- Report: Epi & Market Forecast - Idiopathic Pulmonary Fibrosis (IPF)
- Report: KOL Interview - Acute Lymphoblastic Leukemia | Cystic Fibrosis | Neuroendocrine Tumors
Latest Editorial Podcasts
